Targeting cardiac and cerebrovascular risks of sarcopenia: Is it time to screen for muscle health?
J Am Geriatr Soc
.
2024 Mar;72(3):654-657.
doi: 10.1111/jgs.18777.
Epub 2024 Jan 19.
Authors
Saeid Mirzai
1
,
W H Wilson Tang
2
Affiliations
1
Section on Cardiovascular Medicine, Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
2
Kaufman Center for Heart Failure Treatment and Recovery, Heart Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.
PMID:
38241461
PMCID:
PMC10947918
(available on
2025-03-01
)
DOI:
10.1111/jgs.18777
No abstract available
Publication types
Editorial
MeSH terms
Humans
Muscle Strength / physiology
Muscle, Skeletal / pathology
Sarcopenia* / diagnosis
Grants and funding
R01 HL146754/HL/NHLBI NIH HHS/United States
T32 HL076132/HL/NHLBI NIH HHS/United States
R01HL146754/HL/NHLBI NIH HHS/United States
T32HL076132/HL/NHLBI NIH HHS/United States